Table 2.
Medication | Glass Vial Preparation | Prefilled Syringes | ||||||
---|---|---|---|---|---|---|---|---|
Infections | Total Injections | Infection Rate, % (per No. of Injections) |
Infections | Total Injections | Infection Rate, % (per No. of Injections) |
Relative Risk (95% CI) |
P Value | |
Ranibizumab combined a | 13 | 34 790 | 0.037 (1 of 2702) |
17 | 112 809 | 0.015 (1 in 6666) |
0.403 (0.196-0.830) |
.017 * |
Aflibercept | 41 | 68 076 | 0.060 (1 of 1666) |
7 | 29 899 | 0.023 (1 in 4348) |
0.389 (0.174-0.866) |
.018 * |
Total | 54 | 102 866 | 0.052 (1 of 1923) |
24 | 142 708 | 0.017 (1 in 5882) |
0.320 (0.198-0.518) |
<.001 ** |
Includes doses 0.5 mg/0.05 mL and 0.3 mg/0.05 mL.
p < .05; **p < .001.